Mechanisms of escape from trastuzumab-mediated ADCC in esophageal squamous cell carcinoma.

食管鳞状细胞癌中曲妥珠单抗介导的 ADCC 的逃逸机制。

基本信息

  • 批准号:
    20790947
  • 负责人:
  • 金额:
    $ 2.75万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
  • 财政年份:
    2008
  • 资助国家:
    日本
  • 起止时间:
    2008 至 2009
  • 项目状态:
    已结题

项目摘要

We elucidated the mechanisms of escape from trastuzumab-mediated ADCC using esophageal squamous cell carcinoma cell clones. The ADCC assay with purified NK cells showed significantly susceptibility to trastuzumab-mediated ADCC in tumor cell clones. These results indicated that the sensitivity to trastuzumab-mediated ADCC was mainly due to the difference in susceptibility to NK cell-mediated ADCC. Furthermore, the degree of permeabilization induced by PFN and apoptosis induced by the combination of PFN with GrB in tumor cell clones was analyzed. As a result, lower sensitivity for PFN/GrB on tumor clones was related to the reduced trastuzumab-mediated ADCC. In conclusion, lower susceptibility to the perforin-granzyme system is one of the important mechanisms explaining escape from trastuzumab-mediated ADCC.
我们使用食管鳞状细胞癌细胞克隆阐明了逃避曲妥珠单抗介导的ADCC的机制。纯化NK细胞的ADCC试验显示肿瘤细胞克隆对曲妥珠单抗介导的ADCC具有显著敏感性。这些结果表明,对曲妥珠单抗介导的ADCC的敏感性主要是由于对NK细胞介导的ADCC的敏感性差异。此外,分析PFN诱导的透化程度和PFN与GrB组合诱导的肿瘤细胞克隆的凋亡。因此,PFN/GrB对肿瘤克隆的敏感性较低与曲妥珠单抗介导的ADCC降低有关。总之,对穿孔素-颗粒酶系统的敏感性降低是解释曲妥珠单抗介导的ADCC逃逸的重要机制之一。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Mechanisms of escape from trastuzumab-mediated ADCC in esophageal squamorscell carcinoma.
食管鳞状细胞癌中曲妥珠单抗介导的 ADCC 的逃逸机制。
  • DOI:
  • 发表时间:
    2009
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kono K;Mizukami Y;Daigo Y;Takano A;Masuda K;Yoshida K;Tsunoda T;Kawaguchi Y;Nakamura Y;Fujii H;Yoshihiko Kawaguchi
  • 通讯作者:
    Yoshihiko Kawaguchi
Protein-bound polysaccharide K (PSK) partially prevents apoptosis of circulating T cells induced by anti-cancer drug S-1 in patients with gastric cancer
蛋白结合多糖 K (PSK) 部分阻止胃癌患者抗癌药物 S-1 诱导的循环 T 细胞凋亡
  • DOI:
  • 发表时间:
    2008
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Mizukami Y;Kono K;Kawaguchi Y;Akaike H;Kamimura K;Sugai H;Fujii H;Yoshiki Mizukami;Koji Kono
  • 通讯作者:
    Koji Kono
Localization Pattern of Foxp3^+ Regulatory T cells is associated with Clinical Behavior in Gastric Cancer
Foxp3^ 调节性 T 细胞的定位模式与胃癌的临床行为相关
  • DOI:
  • 发表时间:
    2008
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Mizukami Y;Kono K;Kawaguchi Y;Akaike H;Kamimura K;Sugai H;Fujii H;Yoshiki Mizukami;Koji Kono;Yoshiki Mizukami;Yosihki Mizukami
  • 通讯作者:
    Yosihki Mizukami
Downregulation of HLA Class I molecules in the tumour is associated with a poor prognosis in patients with oesophageal squamous cell carcinoma.
  • DOI:
    10.1038/sj.bjc.6604715
  • 发表时间:
    2008-11-04
  • 期刊:
  • 影响因子:
    8.8
  • 作者:
    Mizukami Y;Kono K;Maruyama T;Watanabe M;Kawaguchi Y;Kamimura K;Fujii H
  • 通讯作者:
    Fujii H
Protein-Bound Polysaccharide K Partially Prevents Apoptosis of Circulating T Cells Induced by Anti-Cancer Drug S-1 in Patients with Gastric Cancer
  • DOI:
    10.1159/000151361
  • 发表时间:
    2008-08
  • 期刊:
  • 影响因子:
    3.5
  • 作者:
    K. Kono;Y. Kawaguchi;Y. Mizukami;K. Mimura;H. Sugai;H. Akaike;H. Fujii
  • 通讯作者:
    K. Kono;Y. Kawaguchi;Y. Mizukami;K. Mimura;H. Sugai;H. Akaike;H. Fujii
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KAWAGUCHI Yoshihiko其他文献

KAWAGUCHI Yoshihiko的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KAWAGUCHI Yoshihiko', 18)}}的其他基金

Local self-governance in modern Japan --- legal history of the relationship between an administrative village and hamlets
近代日本的地方自治——行政村与小村关系的法制史
  • 批准号:
    18H00792
  • 财政年份:
    2018
  • 资助金额:
    $ 2.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of the anti-HER3 antibody therapy for esophageal squamous cell carcinoma.
食管鳞状细胞癌抗HER3抗体疗法的开发。
  • 批准号:
    24591936
  • 财政年份:
    2012
  • 资助金额:
    $ 2.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanisms of escape from trastuzumab-mediated ADCC in esophageal squamous cell carcinoma.
食管鳞状细胞癌中曲妥珠单抗介导的 ADCC 的逃逸机制。
  • 批准号:
    22791268
  • 财政年份:
    2010
  • 资助金额:
    $ 2.75万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
The Formation and Transformation of Modern Land-ownership Structure in Japan?The Legal History of Land and "Mura(Village)"
日本近代土地所有制结构的形成与变迁?土地法制史与“村”
  • 批准号:
    21530013
  • 财政年份:
    2009
  • 资助金额:
    $ 2.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Legal history of "conciliation" in comparison
“调解”的法律历史比较
  • 批准号:
    18330004
  • 财政年份:
    2006
  • 资助金额:
    $ 2.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
A study of law historical study of Agricultural Land Law
农地法的法史研究
  • 批准号:
    15530013
  • 财政年份:
    2003
  • 资助金额:
    $ 2.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Study of Agricultural Land Iaw in legal history
法制史上农地法研究
  • 批准号:
    12620012
  • 财政年份:
    2000
  • 资助金额:
    $ 2.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Targeted Anchoring Ecto-enzyme on Cancer Cell Surface to Enhance Antibody Therapy in Breast Cancer
靶向锚定癌细胞表面的胞外酶以增强乳腺癌的抗体治疗
  • 批准号:
    10353727
  • 财政年份:
    2021
  • 资助金额:
    $ 2.75万
  • 项目类别:
Targeted Anchoring Ecto-enzyme on Cancer Cell Surface to Enhance Antibody Therapy in Breast Cancer
靶向锚定癌细胞表面的胞外酶以增强乳腺癌的抗体治疗
  • 批准号:
    10539331
  • 财政年份:
    2021
  • 资助金额:
    $ 2.75万
  • 项目类别:
Enhancing tumor-targeted antibody therapy with a second NK activating antibody.
使用第二种 NK 激活抗体增强肿瘤靶向抗体治疗。
  • 批准号:
    8111155
  • 财政年份:
    2010
  • 资助金额:
    $ 2.75万
  • 项目类别:
Enhancing tumor-targeted antibody therapy with a second NK activating antibody.
使用第二种 NK 激活抗体增强肿瘤靶向抗体治疗。
  • 批准号:
    8465200
  • 财政年份:
    2010
  • 资助金额:
    $ 2.75万
  • 项目类别:
Enhancing tumor-targeted antibody therapy with a second NK activating antibody.
使用第二种 NK 激活抗体增强肿瘤靶向抗体治疗。
  • 批准号:
    8265662
  • 财政年份:
    2010
  • 资助金额:
    $ 2.75万
  • 项目类别:
ANTIBODY THERAPY FOR BREAST CANCER: INVESTIGATION OF IMMUNE MODULATION WITH IL-21
乳腺癌抗体治疗:IL-21 免疫调节研究
  • 批准号:
    7313944
  • 财政年份:
    2007
  • 资助金额:
    $ 2.75万
  • 项目类别:
ANTIBODY THERAPY FOR BREAST CANCER: INVESTIGATION OF IMMUNE MODULATION WITH IL-21
乳腺癌抗体治疗:IL-21 免疫调节研究
  • 批准号:
    8325703
  • 财政年份:
    2002
  • 资助金额:
    $ 2.75万
  • 项目类别:
ANTIBODY THERAPY FOR BREAST CANCER: INVESTIGATION OF IMMUNE MODULATION WITH IL-21
乳腺癌抗体治疗:IL-21 免疫调节研究
  • 批准号:
    7916683
  • 财政年份:
    2002
  • 资助金额:
    $ 2.75万
  • 项目类别:
ANTIBODY THERAPY FOR BREAST CANCER: INVESTIGATION OF IMMUNE MODULATION WITH IL-21
乳腺癌抗体治疗:IL-21 免疫调节研究
  • 批准号:
    8139925
  • 财政年份:
    2002
  • 资助金额:
    $ 2.75万
  • 项目类别:
ANTIBODY THERAPY FOR BREAST CANCER: INVESTIGATION OF IMMUNE MODULATION WITH IL-21
乳腺癌抗体治疗:IL-21 免疫调节研究
  • 批准号:
    7682171
  • 财政年份:
    2002
  • 资助金额:
    $ 2.75万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了